Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.
- Published In:
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54(11), 1642-51 (2012)
- Authors:
- Stanley, Takara L(3), Falutz, Julian, Marsolais, Christian, Morin, Josée, Soulban, Graziella, Mamputu, Jean-Claude, Assaad, Hani, Turner, Ralph, Grinspoon, Steven K
- Database ID:
- RPEP-02077
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02077APA
Stanley, Takara L; Falutz, Julian; Marsolais, Christian; Morin, Josée; Soulban, Graziella; Mamputu, Jean-Claude; Assaad, Hani; Turner, Ralph; Grinspoon, Steven K. (2012). Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54(11), 1642-51. https://doi.org/10.1093/cid/cis251
MLA
Stanley, Takara L, et al. "Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012. https://doi.org/10.1093/cid/cis251
RethinkPeptides
RethinkPeptides Research Database. "Reduction in visceral adiposity is associated with an improv..." RPEP-02077. Retrieved from https://rethinkpeptides.com/research/stanley-2012-reduction-in-visceral-adiposity
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.